Literature DB >> 1392340

Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks.

K Yamaguchi1, M Enjoji.   

Abstract

A total of 24 patients with endocrine neoplasms of the pancreas were clinicopathologically and immunohistochemically studied. They consisted of 18 patients with adenoma and 6 with carcinoma. Of the 24 patients, 13 developed attacks of hypoglycemia due to hyperinsulinemia, and 1 developed an uncontrollable duodenal ulcer caused by the hypersecretion of gastrin, however, the remaining 10 were asymptomatic. No prediction could be made as to the site of origin of the tumors. A clear difference was seen between adenoma and carcinoma in the size of the mass, the mean greatest diameter of the 18 adenoma cases being 1.7 cm, while that of the 6 carcinoma cases was 7.3 cm. One of the 13 insulinomas and a gastrinoma was malignant, while all 24 tumors were positive for neuron-specific enolase. The 13 insulinomas were diffusely positive for insulin and 5 were also shown to be focally immunoreactive for gastrin, with 3 also being immunoreactive for somatostatin and 2 for pancreatic polypeptide. The gastrinoma showed immunoreactivity for somatostatin, insulin, pancreatic polypeptide, and glucagon in addition to a positivity to gastrin. The above findings thus indicate the multiple hormone synthesis of endocrine neoplasms of the pancreas.

Entities:  

Mesh:

Year:  1992        PMID: 1392340     DOI: 10.1007/bf00308737

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

1.  Islet cell carcinoma of the pancreas.

Authors:  A L Cubilla; S I Hajdu
Journal:  Arch Pathol       Date:  1975-04

2.  Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment.

Authors:  M R Blackman; B D Weintraub; S W Rosen; I A Kourides; K Steinwascher; M H Gail
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

3.  The human pancreatic islet cells and their tumors. II. Ulcerogenic and diarrheogenic tumors.

Authors:  M H Greider; J Rosai; J E McGuigan
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

4.  Secretion of various endocrine substances by ACTH-secreting tumors--gastrin, melanotropin, norepinephrine, serotonin, parathormone, vasopressin, glucagon.

Authors:  L W O'Neal; D M Kipnis; S A Luse; P E Lacy; L Jarett
Journal:  Cancer       Date:  1968-06       Impact factor: 6.860

5.  Distribution of tissue polypeptide antigen (TPA) in normal human tissues: Immunohistochemical study on unfixed, methanol-, ethanol-, and formalin-fixed tissues.

Authors:  W B Nathrath; P Heidenkummer; V Björklund; B Björklund
Journal:  J Histochem Cytochem       Date:  1985-02       Impact factor: 2.479

6.  Synaptophysin. A new and promising pan-neuroendocrine marker.

Authors:  V E Gould
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

7.  Neuron-specific enolase is produced by neuroendocrine tumours.

Authors:  F J Tapia; J M Polak; A J Barbosa; S R Bloom; P J Marangos; C Dermody; A G Pearse
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

8.  Estrogen and progesterone receptor determination in the papillary cystic neoplasm of the pancreas. With immunohistochemical and ultrastructural observations.

Authors:  M Ladanyi; S Mulay; J Arseneau; P Bettez
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

9.  Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).

Authors:  W Creutzfeldt; R Arnold; C Creutzfeldt; N S Track
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

10.  Insulinoma. An immunocytochemical and morphologic analysis of 95 cases.

Authors:  T H Liu; H C Tseng; Y Zhu; S X Zhong; J Chen; Q C Cui
Journal:  Cancer       Date:  1985-09-15       Impact factor: 6.860

View more
  4 in total

1.  Multihormonality and entrapment of islets in pancreatic endocrine tumors.

Authors:  Y Kapran; J Bauersfeld; M Anlauf; B Sipos; G Klöppel
Journal:  Virchows Arch       Date:  2006-01-18       Impact factor: 4.064

Review 2.  Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

Authors:  Tetsuhide Ito; Guillaume Cadiot; Robert T Jensen
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

3.  Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Authors:  David C Metz; Guillaume Cadiot; Pierre Poitras; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2017-10-11

4.  Insulinoma and gastrinoma syndromes from a single intrapancreatic neuroendocrine tumor.

Authors:  Maya B Lodish; Anathea C Powell; Mones Abu-Asab; Craig Cochran; Petra Lenz; Steven K Libutti; James F Pingpank; Maria Tsokos; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.